baber/WOPTO huggingface dataset:
Patent NZ-586129-A (NZ)
Title: Therapeutic compounds and their use in treating diseases and disorders
Inventor: BAJJI ASHOK C
IPC: A01N43/04
Filed: 2008-11-14
Abstract: The disclosure relates to piperidin-purin-oxoindane derivative compounds of formulae (Ia) and (Ib), wherein the variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising these compounds which are suitable for the treatment of a disease or disorder that responds to the inhibition of molecular chaperone protein Hsp90 (Heat Shock Protein 90) chosen from inflammatory diseases, infections, autoimmune disorders, stroke, ischemia, cardiac disorders, neurological disorders, fibrogenetic disorders, proliferative disorders, tumors, leukemias, neoplasms, cancers, carcinomas, metabolic diseases, and malignant disease, scleroderma, polymyositis, systemic lupus, rheumatoid arthritis, liver cirrhosis, keloid formation, interstitial nephritis and pulmonary fibrosis.
Patent NZ-587880-A (NZ)
Title: Fused morpholine derivatives
Inventor: AHN SUNG OH
IPC: C07D498/04
Filed: 2009-03-31
Abstract: The disclosure relates to heterocyclic pyrido-oxazine derivatives of formula (I) wherein the variables shown in formula (I) are as defined in the specification. that are useful for the preparation of medicaments for treatment or prophylaxis of hyperuricemia, gout disease, nephritis, chronic renal failure, nephrolithiasis, uremia, urolithiasis, or disease associated with uric acid, such as hyperlipidemia, ischemic heart disease, myocardial infarction, cerebral infarction, cerebrovascular disease, diabetes or hypertension,
Patent NZ-591704-A (NZ)
Title: Peptide vaccines for cancers expressing tumor-associated antigens
Inventor: TSUNODA TAKUYA
IPC: A61K38/00
Filed: 2008-02-21
Abstract: Provided is a peptide of less than about 15 amino acids having cytotoxic T cell inducibility, wherein said peptide comprises a specified amino acid sequence of 10 amino acids. Further provided are exosomes presenting on its surface the peptide and an HLA antigen. The peptide can be used in vaccines for inhibiting various cancers.
Patent NZ-595340-A (NZ)
Title: Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
Inventor: MAKSYMOWYCH WALTER P
IPC: A61K39/395
Filed: 2006-10-31
Abstract: Disclosed is the use of an anti-TNF? antibody, or antigen-binding portion thereof in the manufacture of a medicament for use in a method of treating a subject having ankylosing spondylitis (AS), the method comprising: determining a post-treatment level of a collagen degradation biomarker and a post-treatment level of a synovitis biomarker in a sample(s) obtained from the subject; and administering to the subject having AS, provided that the post-treatment level of the collagen degradation biomarker in the sample(s) is lower than a known standard level of the collagen degradation biomarker associated with AS, and that the post-treatment level of the synovitis biomarker in the sample(s) is lower than a known standard level of the synovitis biomarker associated with AS, thereby treating the subject having AS.
Patent NZ-601544-A (NZ)
Title: Combination therapy for the treatment of ocular neovascular disorders
Inventor: SHIMA DAVID
IPC: A61K45/00
Filed: 2004-08-26
Abstract: 601544 Disclosed is a pharmaceutical combination comprising: (i) a PDGF-B antagonist; and (ii) a VEGF-A antagonist; wherein the PDGF-B antagonist is a pegylated or unpegylated aptamer having the sequence: CAGGCUACGN CGTAGAGCAU CANTGATCCU GT having 2'-fluoro-2'deoxyuridine at positions 6, 20 and 30; 2'fluoro-2'-deoxycytidine at positions 8,21,28 and 29; 2'-O-Methyl-2'-deoxyguanosine at positions 9,15,17 and 31; 2'-O-Methyl-2'-deoxyadenosine at position 22; "N" in positions 10 and 23 from a hexaethylene-glycol phosphoramidite and an inverted orientation T at position 32; and the VEGF-A antagonist is an antibody or binding fragment thereof; and wherein the PDGF-B antagonist and VEGF-A antagonist are formulated for sequential or simultaneous administration to a patient. Further disclosed is the use of said PDGF-? antagonist in the manufacture of a medicament for sequential or simultaneous administration with a VEGF-A antagonist as described above for treating an ocular neovascular disorder.
Patent NZ-602962-A (NZ)
Title: Thermodynamic cycle and heat engines
Inventor: RISLA NES HARALD
IPC: F02G1/047
Filed: 2011-03-25
Abstract: 602962 A method for heat exchanging in and work exchanging with a working fluid in a heat engine, or a heat pump if the method and its sub-processes are substantially reversed, is described, wherein a thermodynamic cycle for the working fluid is approximately described through the polytropic relation PVn = constant, where P is the pressure, V is the volume and n is the polytropic index of the working fluid with adiabatic index gamma (Υ), and wherein the engine consists of at least one working mechanism (1) provided with a first (150) and at least a second volume change chamber (151, 151’), the method comprising in sequence at least the following steps: a) in a first volume change process, to carry out a first polytropic volume change of the working fluid in a first volume change chamber (150) where n < Y, and b) in a second volume change process, to carry out at least one second near-adiabatic or polytropic volume change of the working fluid from a first (150) to a second (151) volume change chamber, where n < Υ, or where a volume change starts with n < Υ and ands near-adiabatic (n ≈ Υ). Also described is a heat engine arrangement for practicing the method.
Patent NZ-616405-A (NZ)
Title: Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
Inventor: LEEN ANN MARIE
IPC: A61K39/00
Filed: 2012-04-05
Abstract: Discloses an isolated immune system cell comprising a chimeric cytokine receptor comprising a cytokine-binding exodomain and a signal transducing endodomain, wherein the exodomain is IL4 exodomain and the endodomain is IL7 endodomain and/or the exodomain is IL13 exodomain and the endodomain is IL2 endodomain. Also discloses related methods of producing such cells and use in treating cancer.
Patent NZ-623456-A (NZ)
Title: Genetically modified major histocompatibility complex mice
Inventor: MACDONALD LYNN
IPC: A01K67/027
Filed: 2012-10-26
Abstract: Disclosed is a non-human animal comprising at an endogenous Major Histocompatibility Complex I (MHC I) locus a nucleotide sequence encoding a chimeric human/non-human MHC I polypeptide, wherein a human portion of the chimeric polypeptide comprises α1, α2, and α3 domains of a human MHC I polypeptide, and wherein the non-human animal expresses the chimeric human/non-human MHC I polypeptide.
Patent NZ-624159-A (NZ)
Title: Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Inventor: ANDERBERG JOSEPH
IPC: C12Q1/68
Filed: 2009-11-21
Abstract: A method for evaluating renal status in a subject ex vivo, comprises performing one or more assays configured to detect a kidney injury marker on a body fluid sample obtained previously from the subject to provide one or more assay results, the kidney injury marker being Epidermal growth factor; and correlating the assay result(s) to one or more of risk stratification, staging, prognosis, classifying and monitoring of the renal status of the subject. The correlating step comprises assigning a likelihood or risk of future acute renal failure (ARF) suffered by the subject.
Patent NZ-625685-A (NZ)
Title: Compositions and methods for the stability of reactive amino acids in a food matrix
Inventor: MATEUS MARIE-LOUISE
IPC: A23L7/10
Filed: 2013-01-03
Abstract: The present disclosure provides products and methods that provide for the stability of functional amino acids in food matrices. Particularly disclosed is a solid food product comprising: at least one source of solid ingredients selected from a group consisting of: beta-glucans, crisps, rice crisps, rolled oats, fruit pieces, and combinations thereof; and at least one reactive amino acid in a binder that is substantially free from any reducing sugars, wherein the reactive amino acid is selected from beta-alanine and carnosine. Methods for improving the stability of functional amino acids in food matrices are also provided. The products and methods of the present disclosure provide several advantages including, for example, the reduction or avoidance of degradation and browning of the products during processing and storage.
Patent NZ-629845-A (NZ)
Title: Purification method for vitamin k dependent proteins by anion exchange chromatography
Inventor: MITTERER ARTUR
IPC: C12N9/74
Filed: 2014-03-14
Abstract: A method for the separation of inactive Vitamin K dependent protein from active Vitamin K dependent protein in a method for the purification of a Vitamin K dependent protein is disclosed. The method comprises the steps of (a) loading an anion exchange resin material (in the following also “the first anion exchange resin material”) with the Vitamin K dependent protein in a loading buffer in the absence or low concentration of divalent cations, optionally followed by one to three wash steps and (b) eluting the Vitamin K dependent protein with an eluant comprising calcium and a counter-anion to form an eluate containing the Vitamin K dependent protein where: 1-3 mM calcium is comprised in the eluant; the eluant has a conductivity of 14 – 23 mS/cm, and the pH of the eluant is between 7.0 and 9.0. Step (b) is selected from the following group: - the conductivity is between 18 and 20 mS/cm at a pH of 7.0 -7.4 and 1 mM Ca++, - the conductivity is between 18.5 and 21 mS/cm at a pH of 7.4 – 7.6 and 1 mM Ca++, - the conductivity is between 19 and 22.5 mS/cm at a pH of 7.6 – 8.0 and 1 mM Ca++, or - the conductivity is between 20 and 23 mS/cm at a pH of 8.0 – 9.0 and 1 mM Ca++, - the conductivity is between 15 and 17.0 mS/cm at a pH of 7.0 – 7.4 and 2 mM Ca++, - the conductivity is between 16 and 18 mS/cm at a pH of 7.4 – 7.6 and 2 mM Ca++, - the conductivity is between 19.5 and 22 mS/cm at a pH of 8.0 – 9.0 and 2 mM Ca++, - the conductivity is between 14.0 and 15 mS/cm at a pH of 7.0 – 7.4 and 3 mM Ca++, - the conductivity is between 15 and 15.5 mS/cm at a pH of 7.4 – 7.6 and 3 mM Ca++, - the conductivity is between 14 and 16.5 mS/cm at a pH of 7.6 – 8.0 and 3 mM Ca++, or - the conductivity is between 15 and 19 mS/cm at a pH of 8.0 – 9.0 and 3 mM Ca++.
Patent NZ-721874-A (NZ)
Title: Methods for control of aquatic weeds using herbicidal 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acids
Inventor: MANN RICHARD K
IPC: A01N37/40
Filed: 2015-01-29
Abstract: Methods for controlling aquatic weeds that involve the use of 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acids and agriculturally acceptable esters or salts thereof are described. Preferred herbicidal compositions allow for effective control and/or selectivity when treating a body of water to control target aquatic weed populations, such as a hydrilla, Eurasian watermilfoil and/or curlyleaf pondweed.
Patent NZ-736076-A (NZ)
Title: A liner
Inventor: TAN TECK SOON
IPC: B32B27/12
Filed: 2016-04-14
Abstract: The invention solves the problem of liners, such as wth transportation container liners, of maintaining constant temperature and breathability of cargo inside the liner while protecting the cargo from moisture damage. There is disclosed liner for protecting goods against damage from condensation, comprising: a breathable material having a breathable film layer laminated to a breathable support layer, wherein the breathable film layer is a non-perforated layer and allows vapour to transfer across the breathable material but inhibits the transfer of liquids; a breathable reflective material laminated to the breathable material, wherein the breathable reflective material is perforated before lamination to the breathable material and has a reflectivity of equal to or more than 80%; wherein the water vapour transmission rate of the breathable reflective material is greater than the water vapour transmission rate of the breathable film layer; and wherein the breathable material can withstand a hydrostatic pressure of 250 mm or greater.
Patent NZ-741406-A (NZ)
Title: Neuroactive steroid formulations and methods of treating cns disorders
Inventor: REDDY KIRAN
IPC: A61P25/00
Filed: 2013-01-23
Abstract: Disclosed is an aqueous pharmaceutical composition comprising allopregnanolone at a concentration of about 5 mg/mL, sulfo butyl ether β-cyclodextrin at a concentration of about 250 mg/mL, and a citrate buffer, wherein the pH of the composition is from 5 to 9, and wherein the aqueous pharmaceutical composition is contained within a glass vial.
Patent NZ-743630-A (NZ)
Title: Pre-filled drinking straw with a cross-slit valve closure on both ends
Inventor: NOLIMAL BORIS
IPC: A47G21/18
Filed: 2015-12-22
Abstract: Known designs of pre-filled straws use a one-way valve on either inlet or outlet, and use different types of closures such as caps, grids and/or filters of different mesh sizes as a closure of the other opening. Generally, the straw is assembled from a straw body and the closure mechanism is then inserted into the straw. This leads to additional assembly steps in production as well as a need for the use of additional design features preventing the closure to fall out of the straw before or during use. Provided is a pre-filled straw for oral administration of liquid soluble ingredients comprising a straw body (1) consisting of two or more segments, which are attached together with a connection (5). The straw body (1) on both ends has a cross-slit valve (2, 3) closure. Each of the cross-slit valves (2, 3) are positioned to face a direction parallel to the longitudinal axis of the respective segment. The cross-slit valve (2, 3) and the straw body (1) are integrated by molecular adhesion to thereby form a straw and valve integrated in one-piece. This helps facilitate and reduce the cost of the production of a pre-filled straw and its filling. The orientation of the cross-slit valves assists with reducing loss of the straw content due to the cross-slit valves being closed in the time of non-use.
Patent NZ-752616-A (NZ)
Title: Analysis system and method for testing a sample
Inventor: SCHMOLKE HANNAH
IPC: B01F33/40
Filed: 2017-10-05
Abstract: A method for testing a biological sample is proposed, in particular from a human or animal, particularly preferably for analytics and diagnostics, for example with regard to the presence of diseases and/or pathogens and/or for determining blood counts, antibodies, hormones, steroids or the like. Accodingly the disclosure is within the field of bioanalytics. The claimed solution involves testing a biological sample, the sample being received in a cartridge, the sample being conveyed through a fluid system with a plurality of channels of the cartridge, the sample being conveyed to a sensor arrangement of the cartridge in order to detect analytes of the sample, wherein the sample is divided into a plurality of sample portions, the sample portions each being individually conveyed to the sensor arrangement, and wherein a sensor cover of the sensor arrangement is actuated and/or lowered onto a sensor apparatus of the sensor arrangement for pretreatment and/or before detection.
Patent NZ-760936-A (NZ)
Title: Card game monitoring system
Inventor: SHIGETA YASUSHI
IPC: G07F17/32
Filed: 2015-01-16
Abstract: The present invention aims to provide a table game monitoring system with which it is possible to allow casinos to stop an ongoing game immediately when something unexpected happens by administrating the whole game from the start to the end of the game and during payoffs. The card game monitoring system has: a game table on which bettors place bets on betting areas; a card shooter apparatus comprising a card reading unit that reads the number (rank) of a card, a camera system to identify bets on each betting area, and a control unit, wherein the control unit is configured to determine: 1) numbers and positions of the betting chips by utilizing an output of the camera system, 2) for each of the one or more bettors, whether the respective bettor is dealt more than two cards by a dealer from the card shooter apparatus, 3) contents of each hand of the one or more bettors and of the dealer according to the ranks read by the card reading unit, 4) winner(s) of the game according to the game rules and based on each hand of the bettors and the dealer, 5) where any of the one or more bettors is a winning bettor, that a respective payoff, which is to be paid to the respective winning bettor as a result of the game, is correctly paid to the respective winning bettor, in an instance where the payoff is confirmed as being paid directly (a) from the chip tray (b) to a region of the game table that is selectively associated with the respective winning bettor.
Patent NZ-777657-A (NZ)
Title: Seamless access control
Inventor: MARTENS ROBERT
IPC: E05B49/00
Filed: 2019-11-29
Abstract: A method for seamless access control according to one embodiment includes determining whether a user is authorized to access a passageway controlled by an access control device based on credential data received from a mobile device of the user, determining, by a RADAR system, a location of the user relative to the passageway, determining whether the user intends to access the passageway based on the determined location of the user relative to the passageway, and controlling, by the access control device, a lock mechanism to allow the user access to the passageway in response to determining that the user is authorized to access the passageway and the user intends to access the passageway.
Patent PT-104170-A (PT)
Title: Carretel para enrolamento de tubo flexivel de aspiração central
Inventor: FERREIRA CARLOS MANUEL ALMEIDA
IPC: A47L5/38
Filed: 2008-08-26
Abstract: CARRETEL PARA MANTER ENROLADO O TUBO FLEXIVEL DE ASPIRA??O CENTRAL NO LOCAL ONDE FAZ MAIS SERVI?O NO CASO ? A COZINHA, ONDE A SUA UTILIZA??O ? MAIS REQUISITADA AO MESMO TEMPO QUE APROVEITA UM ESPA?O N?O USADO PARA QUALQUER FIM E ENCONTRANDO-SE SEMPRE PRONTO A FUNCIONAR SEM NECESSIDADE DE QUALQUER INTERVEN??O ADICIONAL PERMITE USAR APENAS O COMPRIMENTO DE TUBO REALMENTE NECESS?RIO PERMITE DESENROLAR OU ENROLAR A MANGUEIRA EM UM CURTO ESPA?O DE TEMPO AO MESMO TEMPO QUE A CENTRAL DE ASPIRA??O SE ENCONTRA EM FUNCIONAMENTO.
Patent PT-104499-A (PT)
Title: Sistema para produção de hidrogénio e oxigénio a partir da água do mar para aplicação marítima e industrial e máquina geradora electroquímica com sistema de células a combustível de electrólito misto
Inventor: LEGUA SILVIO SALES DOMINGOS
IPC: B01J7/02
Filed: 2009-04-13
Abstract: SISTEMA PARA PRODUÇÃO DE HIDROGÉNIO E OXIGÉNIO A PARTIR DA ÁGUA DO MAR PARA APLICAÇÃO MARÍTIMA E INDUSTRIAL E MÁQUINA GERADORA ELECTROQUÍMICA COM SISTEMA DE CÉLULAS A COMBUSTÍVEL DE ELECTRÓLITO MISTO. ESTE SISTEMA ELECTROMECÂNICO, O QUAL COMPREENDE UMA MÁQUINA MISTURADOR DE DISSOLUÇÃO, (E2), E UMA MÁQUINA ELECTROLIZADORA AQUECIDA PELO CIRCUITO DE ÁGUA DE ALTA TEMPERATURA, (E3), FOI CONCEBIDO PARA QUE OS TRANSPORTES MARÍTIMOS SE TORNEM ENERGETICAMENTE AUTO-SUSTENTÁVEIS, APROVEITANDO O MEIO EM QUE OPERAM PARA OBTEREM UM GÁS COMBUSTÍVEL, O HIDROGÉNIO. GÁS ESSE QUE É UTILIZADO NUMA MÁQUINA GERADORA COM SISTEMA DE CÉLULAS A COMBUSTÍVEL DE ELECTRÓLITO MISTO, QUE CONVERTE A ENERGIA DA REACÇÃO QUÍMICA EM ENERGIA TÉRMICA E ELÉCTRICA NECESSÁRIA À PROPULSÃO E REDE ELÉCTRICA DO NAVIO. AS VANTAGENS DESTE SISTEMA, ASSENTAM NUMA SIGNIFICATIVA REDUÇÃO DOS CUSTOS DE OPERAÇÃO, E DE FORMA IMEDIATA RESOLVEM UMA SÉRIE DE DESVANTAGENS QUE EXISTEM ACTUALMENTE NA SUA OPERAÇÃO QUER A NÍVEL ECONÓMICO QUER A NÍVEL AMBIENTAL.
Patent PT-105526-A (PT)
Title: Compósitos estruturais de suberina e respectivo processo construtivo
Inventor: ALMEIDA GONCALO NUNO GAGLIARDINI GRACA PEREIRA DE
IPC: C04B16/02
Filed: 2011-02-09
Abstract: COMPÓSITOS ESTRUTURAIS DE SUBERINA CARACTERIZADOS POR CONTEREM NA COMPOSIÇÃO DA SUA MATRIZ CIMENTO, ARGAMASSA, BETÃO OU OUTROS MATERIAIS COMPÓSITOS OU AGLOMERADOS, ENTRE OUTROS, E O BIOPOLIÉSTER SUBERINA. A COMPOSIÇÃO DA MATRIZ DO CIMENTO, ARGAMASSA, BETÃO OU DE OUTROS MATERIAIS COMPÓSITOS OU AGLOMERADOS, ENTRE OUTROS, É MODIFICADA POR ADIÇÃO DO BIOPOLIÉSTER SUBERINA À SUA COMPOSIÇÃO COMO AGENTE DE REVESTIMENTO DA MATRIZ ENDURECIDA, OU POR ADIÇÃO DO BIOPOLIÉSTER SUBERINA DURANTE O AMASSAMENTO DA MATRIZ. DESTA FORMA, O PRESENTE INVENTO É ÚTIL QUANDO SE PRETENDE MELHORAR O DESEMPENHO DO CIMENTO, ARGAMASSA, BETÃO OU DE OUTROS MATERIAIS COMPÓSITOS OU AGLOMERADOS, ENTRE OUTROS, ESPECIFICAMENTE A CAPACIDADE DE IMPERMEABILIZAÇÃO À ÁGUA, O COMPORTAMENTO MECÂNICO, ISOLAMENTO TÉRMICO E ACÚSTICO, A LEVEZA (MASSA VOLÚMICA), A RESISTÊNCIA AO IMPACTO E A RESPOSTA AO FOGO, A VERSATILIDADE E A DURABILIDADE, ENTRE OUTRAS.A PRESENTE INVENÇÃO PODE SER APLICADA EM MATERIAIS DE CONSTRUÇÃO, ENGENHARIA E BIOMIMÉTICA (BIÓNICOS), EM PARTICULAR COM APLICAÇÃO NA INDÚSTRIA DA CONSTRUÇÃO CIVIL E OBRAS-PÚBLICAS E, TAMBÉM, DA MOBILIDADE, COMUNICAÇÕES E CLÍNICA.
Patent PT-107051-A (PT)
Title: Embalagem de porção e sistema de preparação de bebidas compreendendo diferentes tipos da referida embalagem de porção
Inventor: NABEIRO RUI MIGUEL
IPC: B65D85/804
Filed: 2013-07-09
Abstract: A PRESENTE INVENÇÃO REFERE-SE A UMA EMBALAGEM DE PORÇÃO (1) PARA PREPARAÇÃO DE PRODUTOS EDÍVEIS, APRESENTANDO DOIS ELEMENTOS CONSTRUTIVOS (3, 4) ADAPTADOS PARA A ENTRADA E SAÍDA, RESPETIVAMENTE, DE UM ESCOAMENTO FLUIDO SOB PRESSÃO E PELO MENOS UMA CAMADA DE ENVOLVENTE (31, 41) PROPORCIONADA COM UMA PLURALIDADE DE ZONAS DE MATERIAL ENFRAQUECIDO (51, 61) COM UM PADRÃO DE DISTRIBUIÇÃO DE TIPO GRUPOS DAS MESMAS QUE CONDUZ A CARACTERÍSTICAS MELHORADAS DE INTERAÇÃO DO ESCOAMENTO FLUIDO SOB PRESSÃO COM A REFERIDA EMBALAGEM DE PORÇÃO (1), MAIS EFICAZ EM TERMOS DE QUALIDADE DE BEBIDA OBTIDA E SEM NECESSIDADE DE MEIOS DE PERFURAÇÃO DA ENVOLVENTE DE EMBALAGEM. A PRESENTE INVENÇÃO REFERE-SE AINDA A UM SISTEMA DE PREPARAÇÃO DE BEBIDAS (20) INCLUINDO PELO MENOS UMA MÁQUINA DE PREPARAÇÃO DE BEBIDAS (10) COMPREENDENDO PELO MENOS UM DISPOSITIVO DE EXTRAÇÃO (8), E PELO MENOS DOIS TIPOS DE EMBALAGENS DE PORÇÃO (1'A, 1'B) DE CONFIGURAÇÃO E DIMENSÃO SIMILAR, MAS ADAPTADOS PARA DIFERENTES TIPOS DE BEBIDAS OU PARA UMA BEBIDA COM DIFERENTES CARACTERÍSTICAS.
Patent PT-109745-A (PT)
Title: Acessório periférico para dispositivos móveis, de comunicação via infravermelhos e rádio frequência, e respetivo processo de funcionamento
Inventor: GILBERTO CASTRO ALVES
IPC: H04M11/00
Filed: 2016-11-16
Abstract: A PRESENTE INVENÇÃO DIZ RESPEITO A UM ACESSÓRIO PERIFÉRICO (100), QUE FUNCIONA EM CONJUNTO COM UM OU MAIS DISPOSITIVOS MÓVEIS (200), E QUE VISA CONFERIR AOS REFERIDOS DISPOSITIVOS MÓVEIS (200) CAPACIDADE DE COMUNICAÇÃO VIA TECNOLOGIA INFRAVERMELHO (IR) E TECNOLOGIA RADIO FREQUÊNCIA (RF), ATRAVÉS DA SUA FORMA MÍNIMA DE REALIZAÇÃO. A PRESENTE INVENÇÃO DIZ AINDA RESPEITO AO PROCESSO DE FUNCIONAMENTO DO REFERIDO ACESSÓRIO PERIFÉRICO (100), TENDO EM CONSIDERAÇÃO A UTILIZAÇÃO DE UMA APLICAÇÃO INFORMÁTICA (241), EXECUTADA ATRAVÉS DO CONTROLADOR (240) DE UM DISPOSITIVO MÓVEL (200) E A MATERIALIZAÇÃO DE UM CANAL DE COMUNICAÇÃO (1010) ENTRE O REFERIDO ACESSÓRIO PERIFÉRICO (100) E O REFERIDO DISPOSITIVO MÓVEL (200). A PRESENTE INVENÇÃO PERMITE SUBSTITUIR O CONJUNTO DE COMANDOS REMOTOS IR E RF UTILIZADOS PARA INTERAGIR COM APARELHOS OU SISTEMAS COMANDADOS POR ESTE TIPO DE TECNOLOGIAS, COMO POR EXEMPLO: TELEVISORES, SISTEMAS DE SOM, DESCODIFICADORES DE TELEVISÃO, APARELHOS DE CLIMATIZAÇÃO, PORTÕES AUTOMÁTICOS, ESTORES ELÉTRICOS, ENTRE OUTROS.